David Feltl
Impact in
-
- Advanced Breast Cancer Therapies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- Advanced Breast Cancer Therapies 3
- Lung Cancer Diagnosis and Treatment 3
-
- Head and Neck Cancer Studies 6
- Co-authors
- Antonio Llombart‐Cussac (6 shared papers)Matthew J. Ellis (4 shared papers)John Dewar (4 shared papers)J.F.R. Robertson (4 shared papers)Janusz Rolski (4 shared papers)Justin P.O. Lindemann (3 shared papers)Jakub Cvek (15 shared papers)Lukáš Knybel (10 shared papers)
- Journals
- International Journal of Gynecological Cancer (3 papers)Cancer Research (3 papers)Strahlentherapie und Onkologie (3 papers)Journal of Clinical Oncology (2 papers)Oral Oncology (2 papers)
- Partner nations
- CzechiaUnited KingdomSpain
In The Last Decade
David Feltl
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 489
- Oncology 355
- Otorhinolaryngology 48
- Cancer Research 165
- Radiation 90
Countries citing papers authored by David Feltl
This map shows the geographic impact of David Feltl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Feltl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Feltl more than expected).
Fields of papers citing papers by David Feltl
This network shows the impact of papers produced by David Feltl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Feltl. The network helps show where David Feltl may publish in the future.
Co-authors
The 25 scholars most cited alongside David Feltl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 228 | |
| 2 | 2015 | 163 | |
| 3 | 2019 | 130 | |
| 4 | 2012 | 128 | |
| 5 | 2011 | 116 | |
| 6 | 2014 | 63 | |
| 7 | 2016 | 38 | |
| 8 | 2010 | 26 | |
| 9 | 2012 | 24 | |
| 10 | Post-treatment plasma transforming growth factor beta 1 (TGF-beta1) level predicts for late morbidity in patients with advanced head and neck cancer. | 2005 | 18 |
| 11 | 2016 | 18 | |
| 12 | 2015 | 17 | |
| 13 | 2022 | 17 | |
| 14 | 2015 | 16 | |
| 15 | 2006 | 16 | |
| 16 | 2016 | 15 | |
| 17 | 2011 | 14 | |
| 18 | 2014 | 14 | |
| 19 | 2014 | 13 | |
| 20 | 2006 | 12 |
About David Feltl
David Feltl is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Oncology, Genetics and Surgery, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (6 papers), Estrogen and related hormone effects (6 papers), Lymphoma Diagnosis and Treatment (4 papers), Advanced Radiotherapy Techniques (3 papers), Management of metastatic bone disease (3 papers), Advanced Breast Cancer Therapies (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (489 citations), Oncology (355 citations), Otorhinolaryngology (48 citations), Cancer Research (165 citations) and Radiation (90 citations). David Feltl has collaborated with scholars based in Czechia, United Kingdom and Spain. Frequent co-authors include Antonio Llombart‐Cussac, Matthew J. Ellis, John Dewar, J.F.R. Robertson, Janusz Rolski, Justin P.O. Lindemann, Jakub Cvek, Lukáš Knybel, Euan Macpherson and Yuri Rukazenkov. Their work appears in journals such as International Journal of Gynecological Cancer, Cancer Research, Strahlentherapie und Onkologie, Journal of Clinical Oncology and Oral Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.